Article

Encoding Drug-Target-Pathway-Disease profiles for Drug-Cancer Association Prediction using Graph Transformer-Convolution Networks

2025-03-11

Abstract excerpt

New drug development is costly, time-consuming, and has a low success rate, leading to a decline in drug discovery efficiency over time. Drug repurposing has emerged as an effective alternative, applying existing, safe drugs to new diseases, thereby reducing development time and costs by bypassing preclinical toxicology testing. With the increasing availability of large-scale interaction data (e.g., drug-protein,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bf9a5696-ff89-52bb-961c-0f44f9babbc6
DOI: 10.1101/2025.03.05.641572

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Encoding Drug-Target-Pathway-Disease profiles for Drug-Cancer Association Prediction using Graph Transformer-Convolution NetworksDOI 10.1101/2025.03.05.641572Read

Graph Network-Based Analysis of Disease-Gene-Drug Associations: Zero-Shot Disease-Drug Prediction and Analysis StrategiesSemantic proximity Read

NetMedGPT - A network medicine foundation model for extensive disease mechanism mining and drug repurposingSemantic proximity Read

<i>MedGraphNet</i> : Leveraging Multi-Relational Graph Neural Networks and Text Knowledge for Biomedical PredictionsSemantic proximity Read

Integrating Protein-Protein Interaction Information into Drug Response Prediction by Graph Neural EncodingSemantic proximity Read

A prototype-augmented graph representation learning framework for identifying brain disorder-associated genes and facilitating drug repurposing.Semantic proximity Read

ECLIPSE: Exploration of Complex Ligand-Protein Interactions through Learning from Systems-level Heterogeneous Biomedical Knowledge GraphsSemantic proximity Read

Emden: A novel method integrating graph and transformer representations for predicting the effect of mutations on clinical drug response.Semantic proximity Read

DREAM-GNN: Dual-route embedding-aware graph neural networks for drug repositioningSemantic proximity Read

Deep Learning Can Identify Explainable Reasoning Paths of Mechanism of Drug Action for Drug Repurposing from Multilayer Biological NetworkSemantic proximity Read

Network-principled deep generative models for designing drug combinations as graph setsSemantic proximity Read

Identifying Disease-Gene Associations by Topological and Biological Feature-based Data Augmentation and Graph Neural Networks.Semantic proximity Read

GNN-SubNet: disease subnetwork detection with explainable Graph Neural NetworksSemantic proximity Read